Hepatitis A vaccine in pediatric patients affected by metabolic liver diseases

Pediatr Infect Dis J. 2001 Aug;20(8):805-7. doi: 10.1097/00006454-200108000-00018.

Abstract

Twenty children with a variety of metabolic liver diseases were given two doses of hepatitis A vaccine. Adverse reactions were mild. All subjects responded to vaccine with seroconversion to hepatitis A virus antibodies after the first dose, regardless of transaminase values, and had a booster effect from the second doses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Hepatitis A / prevention & control*
  • Hepatitis A Antibodies
  • Hepatitis A Vaccines / administration & dosage
  • Hepatitis A Vaccines / adverse effects*
  • Hepatitis A Vaccines / immunology*
  • Hepatitis A virus / immunology
  • Hepatitis Antibodies / blood
  • Humans
  • Infant
  • Liver Diseases / immunology*
  • Male
  • Vaccination

Substances

  • Hepatitis A Antibodies
  • Hepatitis A Vaccines
  • Hepatitis Antibodies